1ST Source Bank Has $2.30 Million Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

1ST Source Bank lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,777 shares of the financial services provider’s stock after selling 398 shares during the quarter. 1ST Source Bank’s holdings in iShares Biotechnology ETF were worth $2,297,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the third quarter worth $29,000. Highline Wealth Partners LLC bought a new stake in iShares Biotechnology ETF during the third quarter worth $30,000. Ashton Thomas Securities LLC bought a new stake in iShares Biotechnology ETF during the third quarter worth $36,000. Voisard Asset Management Group Inc. bought a new stake in iShares Biotechnology ETF during the third quarter worth $59,000. Finally, Aptus Capital Advisors LLC raised its position in iShares Biotechnology ETF by 36.5% during the third quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after acquiring an additional 114 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB traded down $1.21 on Friday, hitting $136.46. 302,345 shares of the stock were exchanged, compared to its average volume of 1,443,987. The business’s fifty day moving average is $141.99 and its 200 day moving average is $142.24. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.